Drug intelligence / Profile preview

[18F]GATT-44

Development stage
Phase 1
Lead developer
Yale University
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

[18F]GATT-44 is a fluorine-18 labeled small molecule radiotracer developed by Yale University for positron emission tomography (PET) imaging of the GABA transporter type 1 (GAT-1) in the brain. GAT-1 is the primary transporter responsible for the reuptake of gamma-aminobutyric acid (GABA) from the synaptic cleft, playing a vital role in regulating inhibitory neurotransmission. As a diagnostic imaging agent, [18F]GATT-44 is designed to cross the blood-brain barrier and bind specifically to GAT-1, allowing for the quantification of transporter density and occupancy in vivo. This tool is intended to facilitate research into the GABAergic system's involvement in various neuropsychiatric and neurological disorders, such as epilepsy and schizophrenia, by providing a non-invasive method to study GAT-1 distribution and function in the human brain.

02

Targets

SLC6A1 (Sodium- and chloride-dependent GABA transporter 1)

Beyond the preview

Go deeper on [18F]GATT-44.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on [18F]GATT-44.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call